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Whole-body and muscle protein metabolism are not affected by acute
deviations from habitual protein intake in older men: the Hormonal
Regulators of Muscle and Metabolism in Aging (HORMA) Study1–4
Kevin E Yarasheski, Carmen Castaneda-Sceppa, Jiaxiu He, Miwa Kawakubo, Shalender Bhasin, Ellen F Binder,
E Todd Schroeder, Ronenn Roubenoff, Stan P Azen, and Fred R Sattler
ABSTRACT
Background: Acute deviations in protein intake before the quanti-
fication of protein kinetics in older humans may explain the con-
troversy over the effects of older age on muscle protein synthesis
and proteolysis rates.
Objective:We hypothesized that an acute decrease in protein intake
from the habitual intake is associated with lower muscle protein
synthesis and higher proteolysis rates, whereas an acute increase
in protein intake from the habitual intake is associated with higher
muscle protein synthesis and lower proteolysis rates.
Design: In 112 community-dwelling healthy men aged 65–90 y, we
quantified resting whole-body [1,2-13C2]leucine kinetics, muscle
mixed protein fractional synthesis rates (FSRs), and muscle protea-
some proteolytic enzyme activities after participants consumed for
3 d controlled research meals (0.9–1.1 g protein  kg21  d21) that
contained more or less protein than that habitually consumed and
that induced alterations in nitrogen balance.
Results: Protein kinetic parameters were not significantly different
between the groups, despite controlled research protein intakes that
were lower (20.2 to 20.3 g  kg21  d21) or higher (+0.2 g  kg21 
d21) than habitual intakes and that induced negative (222 to 225
mg  kg21  d21) or positive (22–25 mg  kg21  d21) nitrogen
balance. Within these acutely altered protein intake and nitrogen
balance boundaries, a reduction in protein intake from habitual in-
take and induction of negative nitrogen balance were not associated
with higher proteolysis or lower muscle FSR, and an acute increase
in protein intake from habitual intake and induction of positive ni-
trogen balance were not associated with lower proteolysis or higher
muscle FSR. A higher quantitative insulin sensitivity check index was
associated with lower whole-body proteolysis rates.
Conclusions: The practice of acutely controlling protein intake, even
at intakes lower than habitual intakes that induce negative nitrogen
balance, before quantifying human protein kinetics does not signifi-
cantly reduce muscle protein synthesis or increase proteolysis. Factors
other than protein intake explain lower muscle protein synthesis rates
with advanced age. This trial is registered at clinicaltrials.gov as
NCT00183040. Am J Clin Nutr doi: 10.3945/ajcn.110.010959.
INTRODUCTION
Sarcopenia is the loss of muscle protein mass and function
that accompanies advanced age. Sarcopenia is associated with
physical inactivity (1, 2); endocrine changes (3–5); neuronal/
denervation (6, 7); anorexia or insufficient macronutrient intake,
digestion, and absorption (8–11); proinflammatory processes
(12); impaired kidney function (13); and reduced muscle blood
flow (14). These factors contribute to a loss of muscle protein that
ultimately results from changes in the rates of muscle proteolysis
and muscle protein synthesis.
However, the effects of older age on muscle proteolysis and
protein synthesis rates are controversial. Several reports indicate
that resting muscle protein synthesis is lower in older persons
than in young control subjects (2, 15–18), whereas other reports
indicate that aging has no effect on resting muscle protein
synthesis rate (19, 20). One potential explanation for this dis-
crepancy is methodologic. Perhaps the research meals used by
some investigators to control energy and protein intakes for 2 to
3 d before the quantification of muscle protein synthesis rate
lower the rate of muscle protein synthesis or increase the rate of
muscle proteolysis in comparison with measurements madewhen
participants consume their habitual protein and energy intakes.
The underlying premise is that habitual protein and energy
intakes are greater than those provided in research meals and that
a relative protein and energy deficiency introduced by controlled
research meals artifactually lowers the rate of muscle protein
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synthesis or increases the rate of muscle proteolysis measured
after several days of controlled intake. If true, this finding clarifies
the relative contribution of changes in muscle protein synthesis
and proteolysis to sarcopenia.
We tested this hypothesis in the Hormonal Regulators of
Muscle and Metabolism in Aging (HORMA) study, in which
resting muscle protein synthesis and proteolysis rates were
quantified in a relatively large number (n = 112) of healthy men
aged 65–90 y (4, 5). We hypothesized that resting muscle pro-
tein synthesis rates would be lower and muscle proteolysis
higher when habitual protein consumption (g  kg21  d21) was
higher than that consumed over 3 d of controlled research meals
and that the resting muscle protein synthesis rate would be
higher and muscle proteolysis lower when habitual protein
consumption was lower than that consumed over 3 d of con-
trolled research meals. This study tested the importance of
controlling dietary protein intake on the days before the mea-
surement of in vivo protein/amino acid metabolism and directly
addresses the controversy over the influence of acute changes
in protein and energy intakes (3 d) preceding the measures of
muscle protein synthesis and proteolysis. We also collected in-
formation on several potential regulators of muscle protein
synthesis and proteolysis and determined their relative contri-
bution to the resting measures of muscle protein synthesis and
proteolysis.
SUBJECTS AND METHODS
The HORMA was a randomized, controlled, double-masked
multicenter investigation of physiologic supplementation with
testosterone and recombinant human growth hormone given to
65–90-y-old community-dwelling men with testosterone and
insulin-like growth factor I (IGF-I) concentrations typical of
older men (4, 5). The current report focuses only on baseline
(before hormonal interventions) nutritional, metabolic, physio-
logic, and quality-of-life measures.
Study participants
Male participants provided local institutional review board–
approved informed consent and were screened at the University
of Southern California (USC), Tufts University, and Washington
University. Inclusion criteria were as follows: 65–90 y of age,
fasting serum IGF-I concentration in the lower tertile for adults
(,167 ng/mL, or 21.9 nmol/L) and morning total serum testos-
terone in the lower half (150–550 ng/dL, or 5.21–19.1 nmol/L) of
the adult range for males, prostate-specific antigen  4.0 ng/mL,
hematocrit 50%, and fasting blood glucose ,126 mg/dL (6.99
mmol/L). Serum albumin and creatinine were quantified in local
university hospital laboratories, and creatinine clearance was
estimated by using the following equation: [(140 2 age) · body
weight]/72 · serum creatinine (4). None of the men were current
tobacco users. We screened 242 men and enrolled 122 men;
exclusion events are outlined in Figure 1.
Dietary intake
Habitual dietary intake
Habitual nutrient intake was assessed from 3-d dietary diaries
collected from participants before the study and reviewed by the
research nutritionists. Total energy and macronutrient intakes
were quantified by using Nutritionist Pro (Axxya Systems, Staf-
ford, TX). The Harris-Benedict equation (1.3 physical activity
factor) predicted that these men required 2116 6 260 kcal/d
(median: 2096; minimum: 1405; maximum: 2726 kcal/d), and
they reported their habitual energy consumption to be 2198 6
484 kcal/d (median: 2166; minimum: 983; maximum: 3638;
Table 1). These men did not underreport their habitual total
daily energy intake.
Controlled research dietary intake
The participants were admitted to a local Clinical Research
Unit (CRU) for ’20 h. For 2 d before and on the day of ad-
mission, the participants consumed a controlled energy and
protein meal plan based on their self-reported habitual intake.
The controlled research meals consisted of 0.9–1.1 g protein 
kg21  d21 with 50–60% of energy as carbohydrate, 25–35% of
energy as total fat (7% saturated fat), and a total daily energy
intake of 2327 6 399 kcal/d (median: 2326; minimum: 1359;
maximum: 3197 kcal/d). Mean total daily energy intake ex-
ceeded the Harris-Benedict prediction for total daily energy
requirement by 211 6 404 kcal/d (P , 0.0001).
The controlled meals were prepared in the local CRU research
kitchens. The participants were instructed to arrive in the morning
(3 d before testing) and to pick up a cooler that contained all food
that was to be consumed for the 3 d before the isotope-dilution
studies. An additional 500 kcal food was provided in the coolers
in case the participants were still hungry after consuming the
controlled research meals. The participants were instructed to eat
only the food/drink provided and to return all uneaten food. Food/
drink that was not consumed was weighed, and the daily intake
record was corrected accordingly. Total daily nitrogen intake
during the controlled meals was calculated (dietary protein is
’16% nitrogen). The participants consumed 101–296 mg N 
kg21  d21; all but 5 men consumed adequate protein nitrogen
(132 mg N  kg21  d21; 0.83 g protein  kg21  d21) (21). We
compared muscle and whole-body protein kinetics between 4
groups of older men (Table 2): group 1: lower than habitual
protein intake (g  kg21  d21) and negative nitrogen balance
(n = 27); group 2: lower than habitual protein intake and positive
nitrogen balance (n = 40); group 3: higher than habitual protein
intake and negative nitrogen balance (n = 23); and group 4:
higher than habitual protein intake and positive nitrogen balance
(n = 22).
All urine excreted during the CRU admission was collected,
and an aliquot was analyzed for urine urea nitrogen concentration
FIGURE 1. Screening, exclusion, and enrollment of the older men
studied in the Hormonal Regulators of Muscle and Metabolism in Aging
(HORMA) study. IGF1, insulin-like growth factor I; PSA, prostate-specific
antigen.
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in the local university hospital laboratory. Total (24 h) urine
nitrogen excretion was calculated (urea nitrogen is’90% of total
urine nitrogen), and total nitrogen losses were estimated from
urine nitrogen plus 1.75 g N/d (from fecal, dermal, and mis-
cellaneous losses). Nitrogen balance was estimated from total
nitrogen intake minus total nitrogen excretion.
Primary outcome measures
Whole-body leucine rate of appearance, proteolysis rate, and
fractional synthesis rate of mixed muscle proteins
The primary study outcomes were whole-body and muscle
protein metabolism measured in each participant on day 3 of
the controlled research meal plan. The rationale, approach,
and technical procedures for these measures were described
previously (2, 15–18, 22–24). Standardized protocols for
tracer infusion studies and blood and muscle sampling pro-
cedures were applied across the 3 clinical testing centers,
where research team members received training and adhered
to a detailed standard operating procedure manual. All
samples for protein kinetic analyses were analyzed in the
Biomedical Mass Spectrometry Research Facility at Wash-
ington University.
Briefly, at 1800 h (’2 h after the evening meal), a primed
bolus of [1,2-13C2]leucine ([
13C2]Leu; Cambridge Isotope
Laboratories Inc, Waltham, MA; ’98 atom%; 4.58 lmol/kg)
was given, and a 14-h intravenous infusion (1 mg  kg21  d21)
was continued throughout the overnight fasted condition.
Venous blood (7 mL) was collected before the start of the
[13C2]Leu infusion (215, 0 min) and at 30-min intervals
during the last 2 h of the constant infusion (12, 12.5, 13, 13.5,
and 14 h). [13C2]Leu was used (rather than [1-
13C]Leu) be-
cause it provides more 13C incorporation into muscle proteins,
which facilitates mass spectrometric quantitation of the ex-
pected slow rate of amino acid incorporation into muscle
protein.
Plasma Leu and the intracellular product of Leu transamination,
a-keto-isocaproic acid (aKIC), were chemically derivatized (23,
25–27) and [13C2]abundance of each was quantified by using gas
chromatography–quadrupole mass spectrometry [Agilent 6890N
TABLE 1
Participant characteristics1
Mean 6 SD Median (minimum, maximum)
Age (y) 70.2 6 4.2 69 (64, 85)
Nutritional data
Albumin (mg/dL) 4.1 6 0.3 4.1 (3.5, 5.4)
Creatinine clearance (mL/min) 82.5 6 18.5 82.9 (40.2, 162.3)
Habitual energy intake (kcal/d) 2198 6 484 2166 (983, 3638)
Habitual protein intake (g/d) 93 6 24 92 (30, 181)
Habitual carbohydrate intake (g/d) 261 6 82 253 (98, 492)
Habitual fat intake (g/d) 87 6 42 82 (20, 425)
Energy intake, research meal plan (kcal/d) 2327 6 399 2326 (1359, 3197)
Protein intake, research meal plan (g/d) 88 6 14 86 (58, 141)
Carbohydrate intake, research meal plan (g/d) 351 6 72 346 (184, 556)
Fat intake, research meal plan (g/d) 69 6 13 70 (32, 100)
Resting energy expenditure (kcal/d) 1696 6 245 1652 (1206, 2664)
Estimated total daily energy expenditure (kcal/d) 2205 6 318 2148 (1567, 3463)
Body composition
Habitual weight (kg)2 85.2 6 12.7 83.0 (53.7, 121.0)
Research meal plan weight (kg)3 84.7 6 12.5 83.0 (51.5, 115.9)
BMI (kg/m2)4 27.8 6 3.4 27.4 (21.1, 35.1)
Lean body mass (kg) 58.2 6 6.9 57.5 (41.6, 78.0)
Appendicular lean mass (kg) 25.5 6 3.3 25.5 (16.7, 34.0)
Appendicular fat mass (kg) 8.7 6 3.2 8.1 (2.4, 18.7)
Trunk fat mass (kg) 12.7 6 4.3 12.4 (3.5, 26.3)
Body fat (%) 26.3 6 5.4 26.2 (12.4, 39.7)
Endocrine and metabolic data
Total testosterone (ng/dL) 363 6 97 361 (155, 546)
IGF-I (ng/mL) 125 6 34 118 (68, 260)
HOMA-IR (n = 111) 1.58 6 1.03 1.22 (0.21, 6.97)
QUICKI (n = 111) 0.161 6 0.016 0.161 (0.126, 0.224)
Physiologic and behavioral data
_VO2 peak (mL  kg21  min21) (n = 93) 24.6 6 4.9 24.3 (9.2, 36.8)
PASE (n = 100) 147 6 65 143 (29.6, 368.7)
PCS (n = 109) 52 6 6 54 (29, 59)
1 n = 112 unless noted otherwise. PASE, Physical Activity Scale for the Elderly; PCS, SF-12 Physical Component
Score; _VO2, oxygen consumption; IGF-I, insulin-like growth factor I; HOMA-IR, homeostasis model assessment of insulin
resistance; QUICKI, quantitative insulin sensitivity check index.
2 Habitual body weight at the time of screening.
3 Weight on day 3 of the research meals, before testing began.
4 Calculated by using body weight from the controlled research meal period.
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Gas Chromatograph and Agilent 5973N Mass Selective Detector
(GC-MS); Agilent, Palo Alto, CA] (23, 27). The average plasma
[13C2]Leu enrichment during the last 2 h of infusion was used to
calculate the whole-body Leu rate of appearance. The average
plasma [13C2]aKIC enrichment was used to calculate the whole-
body proteolysis rate (23, 27, 28).
Indirect calorimetry was used to quantify resting oxygen con-
sumption and carbon dioxide production rates. Measures (5 min
stabilization plus 15 min collection) were performed twice; before
the infusion started (at 0600 and 0730) and during the last hour
of the [13C2]Leu infusion (1530 and 1600). The Weir equation
was used to convert oxygen and carbon dioxide kinetics to
a measure of resting energy expenditure (29). A 1.3 physical
activity factor was used to estimate total daily energy require-
ments for these men.
Vastus lateralis muscle samples (’100 mg) were obtained
90 min after the infusion started (1930) and at the end of the
infusion (13.5–14 h; 0730–0800). [13C2]Leu enrichment in the
muscle free amino acid pool was quantified by using GC-MS
(22, 24, 30). [13C2]Leu enrichment in mixed muscle pro-
teins was quantified by using GC-combustion-isotope ratio
mass spectrometry (17, 23, 30–32) (Delta+ XL-IRMS; Finnigan,
Bremen, Germany).
The fractional synthesis rate for mixed muscle proteins (MMPs)
was calculated by using the established equation (2, 3, 11, 14–16,
18, 20, 22–24, 26, 30–35):
TABLE 2
Whole-body and muscle protein metabolism as a function of altered protein intake and nitrogen balance in elderly men
Group 1: lower than
habitual protein intake
and negative nitrogen
balance
Group 2: lower than
habitual protein
intake and positive
nitrogen balance
Group 3: higher than
habitual protein
intake and negative
nitrogen balance
Group 4: higher than
habitual protein
intake and positive
nitrogen balance
Overall P
value2
Subjects [n (%)] 27 (24) 40 (36) 23 (21) 22 (19)
Difference in protein intake: research
meals minus habitual intake
(g  kg21  d21)
Mean 6 SD 20.24 6 0.18 20.28 6 0.27 0.21 6 0.133,4 0.22 6 0.183,4 ,0.0001
Median (minimum, maximum) 20.20 (20.71, 20.01) 20.21 (21.38, 20.02) 0.21 (0.03, 0.54) 0.20 (0.01, 0.66)
(% of total energy)
Mean 6 SD 23.2 6 3.1 24.0 6 3.5 1.4 6 2.63,4 0.9 6 2.73,4 ,0.0001
Median (minimum, maximum) 22.3 (29.9, 2.2) 23.8 (216.1, 2.5) 2.1 (25.2, 4.5) 0.8 (24.9, 5.9)
Estimated nitrogen balance
(mg  kg21  d21)
Mean 6 SD 221.5 6 17.1 24.9 6 26.83 224.6 6 15.94 21.9 6 19.43,5 ,0.0001
Median (minimum, maximum) 217.8 (265.9, 21.4) 16.7 (0.1, 134.9) 221.8 (254.5, 21.2) 16.6 (0.3, 84.1)
Habitual weight (kg)6
Mean 6 SD 84.4 6 11.4 82.2 6 13.8 89.2 6 12.5 87.7 6 12.2 0.15
Median (minimum, maximum) 82.9 (64.2, 108.2) 79.8 (53.7, 112.5) 89.1 (69.0, 121.0) 84.3 (73.3, 110.7)
Research meal weight (kg)6
Mean 6 SD 83.6 6 11.0 82.3 6 13.8 88.1 6 12.0 87.1 6 12.1 0.25
Median (minimum, maximum) 81.5 (63.8, 107.6) 80.2 (51.5, 110.6) 88.7 (68.3, 115.9) 84.7 (71.5, 112.7)
Whole-body proteolysis rate
(mg  kg LBM21  h21)6
Mean 6 SD 16.4 6 1.4 15.8 6 2.5 16.0 6 1.4 15.9 6 2.3 0.25
Median (minimum, maximum) 16.4 (13.3, 19.4) 15.8 (10.9, 23.8) 15.8 (14.0, 19.4) 16.3 (12.7, 22.0)
Mixed muscle protein fractional synthesis
rate (%/h) (n = 107)6
Mean 6 SD 0.097 6 0.048 0.085 6 0.025 0.097 6 0.032 0.091 6 0.039 0.49
Median (minimum, maximum) 0.075 (0.048, 0.222) 0.084 (0.041, 0.157) 0.088 (0.056, 0.170) 0.072 (0.051, 0.202)
Chymotrypsin-like enzyme activity
(mU/g)6
Mean 6 SD 46.1 6 20.2 39.2 6 15.6 49.1 6 14.1 42.2 6 13.8 0.11
Median (minimum, maximum) 44.9 (21.0, 92.6) 38.9 (9.5, 69.3) 46.1 (24.2, 80.6) 37.1 (19.7, 74.4)
Trypsin-like enzyme activity (mU/g)6
Mean 6 SD 8.3 6 3.8 7.0 6 3.1 9.0 6 3.2 7.8 6 3.5 0.14
Median (minimum, maximum) 8.0 (3.4, 17.2) 6.4 (1.8, 13.7) 8.5 (3.9, 15.8) 7.2 (3.0, 17.3)
PGPD enzyme activity (mU/g)6
Mean 6 SD 8.7 6 4.9 7.5 6 3.9 10.1 6 4.1 8.9 6 4.1 0.13
Median (minimum, maximum) 6.5 (2.9, 26.0) 6.4 (1.7, 18.4) 8.9 (3.2, 18.1) 7.7 (3.0, 16.3)
1 LBM, lean body mass; PGPD, peptidyl glutamyl peptide hydrolase.
2 Comparison between means (2-sample t test).
3 Significantly different from group 1 after adjustment for multiple comparisons, P  0.01 (post hoc).
4 Significantly different from group 2 after adjustment for multiple comparisons, P  0.01 (post hoc).
5 Significantly different from group 3 after adjustment for multiple comparisons, P  0.01 (post hoc).
6 Post hoc test not appropriate.
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MMP ¼ increment in13C2
Leu enrichment in mixed muscle proteins3 100Þ=
ð13C2 enrichment in the precursor pool 3
amount of time

h

between the 2 muscle samples

ð1Þ
This approach uses estimates for 13C2-enrichment in the true
precursor pool for muscle protein synthesis ([13C2]leucyl-
tRNA); the average muscle free pool [13C2]Leu enrichment or
the average plasma [13C2]aKIC enrichment during the last 2 h of
the [13C2]Leu infusion (15, 17, 24, 30–32, 36).
Muscle proteasome catalytic activity
To assess functional activation of the ubiquitin-proteasome
pathway in skeletal muscle extracts, we measured the 3 best
characterized ATP-ubiquitin–independent peptidase activities in
the 20S proteasome core: chymotrypsin-like, trypsin-like (T-L),
and peptidyl glutamyl peptide hydrolase (37). As described
previously (23), peptidase activities were measured ex vivo
in crude muscle (10 mg) extracts by monitoring the release of
7-amido-4-methylcoumarin (AMC) from synthetic peptide sub-
strates: N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin
(N-suc-LLVY-AMC) for chymotrypsin-like activity, N-tert-
butyloxycarbonyl-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin
(N-t-BOC-LSTR-AMC) for trypsin-like activity and N-benzy-
loxycarbonyl-Leu-Leu-Glu-7-amido-4-methylcoumarin (N-CBZ-
LLE-AMC) for peptidyl glutamyl peptide hydrolase activity. All
reagents were obtained from Sigma Chemical (St Louis, MO).
Tissue extract protein concentrations were quantified by using
the Biuret method, and bovine serum albumin was used as
the reference standard. AMC release was monitored fluoro-
metrically at 37C in 96-well plates. Slopes corresponding to
maximum reaction rates (increase in fluorescence/min) were
compared with AMC standards to quantify the amount of AMC
released. Proteasome peptidase activities were determined in
triplicate by the difference in rates of substrate hydrolysis in
muscle extracts that had been pre-incubated in the absence or
presence of lactacystin (BIOMOL Research Laboratories, Ply-
mouth Meeting, PA)—a proteasome-specific inhibitor (38).
Enzyme activity is expressed as mU/g; one unit of activity is
equivalent to the release of 1 lmol AMC/min under the specified
reaction conditions.
Independent predictors
Body composition
Body weight was measured after an overnight fast and the
morning void and while the participant was wearing only
undergarments, a hospital gown, and no jewelry. Habitual body
weight was measured at screening, when a research nutritionist
assessed habitual protein and energy intake. Research body
weight was measured on day 3 of the controlled meal plan.
Whole-body and regional lean and fat mass were quantified by
using dual energy X-ray absorptiometry (DXA). DXA scanners at
each center were cross-calibrated by scanning the same soft tissue
phantom. Scans were analyzed at the USC Reading Center by an
experienced DXA-certified bionutritionist (4, 5).
Aerobic capacity
At baseline, peak oxygen consumption ( _VO2) was assessed by
using cycle ergometry (4, 5). Peak _VO2 was the highest oxygen
consumption attained when participants could not maintain a
pedaling rate .55 rpm.
Hormone assays
For screening, total serum testosterone was measured by using
immunoassays in the local university hospital laboratories and
IGF-I at Quest Diagnostics (San Juan Capistrano, CA). Insulin
concentrations were analyzed by using an automated enzyme
immunoassay (Tosoh AIA 600 II analyzer; Tosoh Bioscience Inc,
South San Francisco, CA) (4, 5). Insulin resistance was evaluated
by using the homeostasis model assessment of insulin resistance
(HOMA-IR) index (39), and insulin sensitivity was evaluated by
using the quantitative insulin sensitivity check index (QUICKI; 40).
Physical activity and quality of life
Self-reported leisure-time physical activity in the 7 d before
study was assessed by using the Physical Activity Scale for the
Elderly (PASE) questionnaire. Self-reported quality of life was
assessed by using the Short-Form Health Survey (SF-12).
Statistical analyses
Baseline characteristics are presented as means 6 SDs and
medians and ranges. Change in protein intake was calculated as
the difference between controlled research protein intake (g 
kg21  d21) and habitual protein intake (g  kg21  d21). Par-
ticipants were divided into 4 groups, those with reduced or in-
creased protein intake while consuming the controlled research
meals and those with positive or negative nitrogen balance. Two-
sample t tests were performed to compare the physiologic and
metabolic variables between these groups. Relations between
change in protein intake, positive compared with negative ni-
trogen balance, and protein metabolism outcomes were assessed
by using linear regression and were illustrated by using scatter
plots. Spearman’s correlations were used for these nonnormally
distributed variables. Five outcomes were measured in the 4
groups; therefore, post hoc analyses were Bonferroni adjusted to
account for multiple comparisons (P = 0.05/5 = 0.01).
Other potential predictors of baseline protein metabolism
measures were identified by using univariate regression (P ,
0.20). Candidate variables were further screened by stepwise
regression (entry a = 0.10). Partial r2 values were calculated for
each predictor based on the final model for each protein me-
tabolism outcome. Statistical analyses were conducted by using
the Statistical Analysis System (version 9.2; SAS Institute Inc,
Cary, NC).
RESULTS
Participant characteristics
Of the 122 men enrolled, 112 completed all aspects of the study
and provided baseline nutrition, metabolic, and physiologic data
(Table 1). The average difference between habitual body weight at
screening (85.2612.7 kg) and on day 3 of the research meals, just
before testing began (84.76 12.5 kg), was small (20.56 1.7 kg;
median:20.4; minimum: 25.4; maximum: 5.8) but statistically
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significant (P = 0.0003; Table 1). The average time interval be-
tween measures of habitual and research body weight was 55 6
30 d (median: 48; minimum: 6; maximum: 178). The results re-
ported here were not adjusted for this small weight loss because
average weight changed (from 21.1 to + 0.1 kg) when groups
transitioned from habitual to research meals (Table 2), and sta-
tistical adjustment for this did not alter the findings.
Deviations in protein intake
The difference in daily protein intake (g protein/kg) between the
controlled research meals and habitual consumption varied widely,
but was normally distributed (Figure 2A). On average, the dif-
ferences in daily protein and energy intake between the controlled
research and habitual meals were 25 6 25 g protein/d (range:
2101 to 54 g protein/d) and +129 6 375 kcal/d (range: 2943 to
1362 kcal/d). This provided an opportunity to examine whether an
acute change from habitual to controlled protein intake was related
to changes in whole-body and muscle protein metabolism in these
older men. Fifty men were in negative nitrogen balance despite
consuming research meals that matched or exceeded their reported
habitual protein and energy intakes (Tables 1 and 2).
Effects of deviations in protein intake on protein
metabolism
The 112 men were divided into 4 groups based on their protein
consumption and nitrogen balance status (Table 2). Despite
FIGURE 2. A: Frequency distribution for the difference in protein intake (research minus habitual protein; g  kg21  d21) in older men. The number of men
who consumed less protein with the research meal plan than they consumed habitually and those who consumed more protein with the research meal plan than
they consumed habitually was normally distributed. B–F: Correlates of whole-body and muscle protein metabolism in older men. Univariate correlation
analyses among protein intakes that were lower or higher than habitual and induced negative or positive nitrogen balance, and whole-body proteolysis rate (B),
mixed muscle protein fractional synthesis rate (C), and muscle proteolytic enzyme activities [chymotrypsin-like (D), trypsin-like (E), and peptidyl glutamyl
peptide hydrolase (F) activities]. No significant relations were observed (all Spearman regression P values .0.01) regardless of how the change in protein
intake was expressed (% of total energy or g protein  kg21  d21). LBM, lean body mass: Neg, negative; Pos, positive; Bal, balance.
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sizable deviations from habitual to research meal protein in-
takes (median: 23.8 to 2.1% of total energy; minimum: 216%;
maximum: 6%) and changes in nitrogen balance, on average,
whole-body and muscle protein kinetic parameters were not
different between the 4 groups (Table 2), regardless of habitual
or research protein intakes and nitrogen balance status in these
older men.
As previously reported, the muscle free pool [13C2]Leu en-
richment was 766 5% of the plasma [13C2]KIC enrichment (22,
24) (Table 3). When muscle tissue free pool [13C2]Leu was used
to represent the precursor pool for protein synthesis, mixed
muscle protein synthesis rates were 24% higher than when
plasma [13C2]aKIC values were used, but the relations between
muscle protein synthesis rate and all variables were the same
and our conclusions confirmed it, regardless of whether muscle
free pool [13C2]Leu or plasma [
13C2]aKIC was used to represent
the precursor pool for muscle protein synthesis. For this reason,
we report MMP values based on plasma [13C2]aKIC.
The between-group means may mask correlative relations be-
tween changes in habitual and research protein intakes, changes
in nitrogen balance, and protein metabolism outcomes. Using
Spearman’s correlation analyses, we examined relations between
changes (both decrease and increase) in protein intake from
habitual to research meals, nitrogen balance status (negative or
positive), and each of the protein metabolism outcomes (Figure
2). This tested whether greater reductions in protein intake and
a more negative nitrogen balance predicted higher proteolytic
rates and lower muscle protein synthesis rates. It also tested
whether greater increases in protein intake and a more positive
nitrogen balance predicted lower rates of proteolysis and higher
muscle protein synthesis rates. No significant relations were
observed (Figure 2, B–F) regardless of whether we expressed the
changes in protein intake as a percentage of total energy intake or
g  kg21  d21 (data not shown). Thus, acute changes in protein
intake along with changes in nitrogen balance did not predict
any of the whole-body or muscle protein metabolism variables.
Regardless of the magnitude of the reduction in protein intake
between habitual and research meals and the magnitude of neg-
ative nitrogen balance, there was no evidence of higher pro-
teolytic rates or lower muscle protein synthesis rates. Likewise,
the magnitude of the increase in protein intake between habitual
and research meals and the magnitude of positive nitrogen bal-
ance did not predict changes in proteolytic or muscle protein
synthesis rates.
Predictors of protein metabolism
We examined relations between traditional regulators of muscle
protein mass (Table 4) and whole-body and muscle protein
metabolism outcomes. The strongest predictors of whole-body
proteolysis rate were insulin resistance (HOMA-IR) and insulin
sensitivity (QUICKI) indexes; these indexes were closely related
(r = 20.87, P , 0.0001). Better insulin sensitivity was signifi-
cantly associated with lower whole-body proteolysis rates. Based
on partial r2, QUICKI explained 21% of the variance in whole-
body proteolysis rate. However, for all other protein metabolism
outcomes, no covariate identified by stepwise linear regression
analysis explained .7% of the variance associated with that
measure, despite the fact that several of these associations were
expected (Table 4). For example, a higher total testosterone
concentration was associated with a lower muscle proteasome
trypsin-like enzyme activity (partial r2 = 0.07, P = 0.01). Fur-
thermore, greater insulin resistance (HOMA-IR) was associated
with higher proteasome peptidyl glutamyl peptide hydrolase
enzyme activity (partial r2 = 0.05, P = 0.02). Some unexpected
weak associations were also noted. Greater insulin resistance
(HOMA-IR) was associated with higher muscle protein synthesis
rates (partial r2 = 0.04, P = 0.02), and higher albumin concen-
trations were associated with lower muscle protein synthesis rates
(partial r2 = 0.03, P = 0.05). The physiologic relevance of the
stepwise linear associations with small partial r2 values 7% is
questionable despite statistical significance.
On the basis of the principal finding from the stepwise linear
regression analysis that better insulin sensitivity (QUICKI) was
significantly associated with lower whole-body proteolysis rates,
we adjusted the univariate correlation analysis between reduc-
tions and increases in protein intake from habitual to research
meals and whole-body proteolysis rate to determine whether this
altered our original finding. After adjustment for QUICKI, there
was still no evidence of a relation between changes in protein
intake and whole-body proteolysis rate (r2 = 0.004, NS).
DISCUSSION
The findings indicate that controlled research meals that
provide protein intakes at Recommended Dietary Allowance
levels that deviate from habitual protein intake by 64% and
induce changes in nitrogen balance (625 mg  kg21  d21) do
not significantly alter measurements of fasting whole-body pro-
teolysis rates, mixed muscle protein synthesis rates, or muscle
proteolytic enzyme activities in older men. This suggests that
controlling dietary protein intakes for several days before
quantifying muscle protein synthesis does not artifactually lower
the measured rate of fasting muscle protein synthesis in older
men and does not account for advanced age-associated lower
rates of fasting muscle protein synthesis reported by several
(2, 15–18, 24) but not all investigators (19, 20). The findings
indicate that the practice of controlling protein intake and
TABLE 3
13C-Enrichment values in various precursor pools and mixed muscle protein1
Mean 6 SD Median (minimum, maximum)
Plasma [1,2-13C2]Leu (mol % excess) 4.9 6 0.6 4.9 (3.3, 6.6)
Plasma [1,2-13C2]aKIC (mol % excess) 3.6 6 0.4 3.5 (2.4, 5.1)
Muscle free pool [1,2-13C2]Leu (mol % excess) 2.7 6 0.4 2.6 (1.8, 4.3)
Mixed muscle protein [1,2-13C2]Leu (atom % excess) 0.0392 6 0.0141 0.0353 (0.0132, 0.0804)
1 Plasma values represent the average measured during the last 2 h of the tracer infusion. Muscle free pool represents
the average measured 1.5 and 14 h after the tracer infusion. Mixed muscle protein values represent the increment from 1.5
to 14 h of the tracer infusion. aKIC, a-keto-isocaproic acid.
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nitrogen balance for several days (eg, 3 d) before the quantifi-
cation of fasting [13C]Leu kinetics and muscle proteasome en-
zyme activities in older men may not be necessary, as long as
body weight is maintained (64%), protein intake is within 0.9–
1.1 g  kg21  d21, and nitrogen balance is 625 mg  kg21  d21.
We found the magnitude of the difference between habitual and
controlled protein intakes was not associated with significant
changes in fasting [13C]Leu kinetics or muscle proteolytic enzyme
activities in older men. In stepwise linear regression analyses
using many potential regulators of human protein metabolism,
changes in protein and energy intakes were not associated with
resting whole-body proteolysis rates, mixed muscle protein syn-
thesis rates, or muscle proteolytic enzyme activities. Instead, the
strongest predictor of fasting whole-body proteolysis rate was an
index of insulin sensitivity. This implies that knowledge of an
older man’s insulin sensitivity is a more important potential co-
variate than controlling protein energy intake for several days
before quantifying fasting [13C]Leu kinetics or muscle proteolytic
enzyme activities.
Our finding that the insulin sensitivity index was more im-
portant than other traditional regulators of whole-body pro-
teolysis supports and extends previous findings (14, 18, 19, 34,
41, 42). Volpi et al (10, 14, 34, 41) and Rennie et al (19, 42) have
exquisitely shown in older persons that skeletal muscle proteins are
refractory to acute increases in amino acid and insulin concen-
trations that normally stimulate protein synthesis and inhibit pro-
teolysis in younger adults. This suggests that age-related muscle
protein loss may be accelerated by 1) a blunted anabolic response
to acute increases in circulating amino acid and insulin concen-
trations during feeding, and 2) a relative insensitivity to the an-
tiproteolytic actions of modest (’15 lU/mL) or higher insulin
concentrations. In the current study, it is possible that the lack of
association observed among changes in daily protein intake (from
habitual to research meals), nitrogen balance, and fasting whole-
body and muscle protein metabolism (Figure 2) resulted from
blunted protein anabolic and catabolic responses to short-term
(3 d) changes in dietary protein/amino acid intakes in these older
men. Perhaps 3 d of controlled protein and energy research meals
was of insufficient duration to alter whole-body and muscle
protein metabolism in these older men. Despite the blunted an-
tiproteolytic response to insulin in older compared with younger
men, an index of fasting insulin sensitivity remained the strongest
predictor of the whole-body proteolysis rate. This reinforces the
importance of fasting insulin concentrations to regulate pro-
teolysis relative to other variables that influence muscle protein
mass in older men (eg, protein intake, digestion, and absorption;
testosterone and IGF-I concentrations; body composition; and
renal function).
On average, the fasting mixed muscle protein synthesis rates
measured in these older men are higher than those in our previous
studies, which used a similar stable-isotope tracer method
([1-13C]Leu tracer). Still, 33% of the men had low fasting
muscle protein synthesis rates (0.041–0.070%/h) (2, 15–18, 24).
As suggested, quantification of in vivo resting muscle protein
TABLE 4
Univariate and multivariate predictors of baseline protein metabolism measures in older men1
Dependent and independent variables
P (stepwise
regression)2
b Regression
coefficient Partial r2
Whole-body proteolysis rate3
QUICKI ,0.001 277.3 0.21
Mixed muscle protein synthesis rate4
Serum albumin 0.05 20.023 0.03
HOMA-IR 0.02 0.008 0.04
Total lean mass 0.02 20.001 0.04
Muscle proteasome chymotrypsin-like activity5
Age 0.06 0.79 0.04
Creatinine clearance 0.02 0.21 0.03
Muscle proteasome trypsin-like activity6
Total testosterone 0.01 20.005 0.07
HOMA-IR 0.03 0.81 0.04
Muscle proteasome PGPD activity7
Total testosterone 0.08 20.004 0.03
HOMA-IR 0.02 0.90 0.05
1 HOMA-IR, homeostasis model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check
index; PGPD, peptidyl glutamyl peptide hydrolase.
2 All potential predictors represent baseline values. Entry level for stepwise: P , 0.20.
3 Covariates: HOMA-IR (P , 0.0001), QUICKI (P , 0.0001), BMI (P = 0.08), and total lean mass (P = 0.10).
4 Covariates: total energy intake (P = 0.06), HOMA-IR (P = 0.08), total lean mass (P = 0.04), appendicular lean mass
(P = 0.04), serum albumin (P = 0.13), and age (P = 0.14).
5 Covariates: creatinine clearance (P = 0.06), HOMA-IR (P = 0.10), trunk fat mass (P = 0.06), age (P = 0.16),
testosterone (P = 0.13), total energy intake (P = 0.20), difference in total energy intake between research and habitual
intakes (P = 0.17), Physical Activity Scale for the Elderly (P = 0.18), and BMI (P = 0.15).
6 Covariates: total testosterone (P = 0.01), creatinine clearance (P = 0.04), HOMA-IR (P = 0.05), trunk fat mass (P =
0.05), total energy intake (P = 0.14), difference in total energy intake between research and habitual intakes (P = 0.17),
Physical Activity Scale for the Elderly (P = 0.19), QUICKI (P = 0.17), and BMI (P = 0.12).
7 Covariates: total testosterone (P = 0.06), creatinine clearance (P = 0.05), HOMA-IR (P = 0.01), QUICKI (P = 0.06),
trunk fat mass (P = 0.03), BMI (P = 0.08), and appendicular fat mass (P = 0.11).
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synthesis rates is limited by measurement sensitivity and large
intersubject variability (43). Despite the infusion of a double-
labeled tracer ([1,2-13C2]Leu), our CV for mixed muscle protein
synthesis was 39%, which suggested that this variation is not
due to analytic/methodologic variation but rather to biological
variation that remains unaccounted for. A potential explanation
for the higher mean fasting fractional muscle protein synthesis
rates observed here include the fact that the men were relatively
healthy, independent, and physically active. In previous studies,
sedentary older men and women were studied, some of whom
had comorbidities (eg, insulin resistance) and lived in congre-
gate assisted-living facilities (44). The resting mixed muscle
protein synthesis rate was not related to peak aerobic capacity.
This finding differs from that of Henderson et al (18); in uni-
variate and multivariate analyses, the natural logarithm of _VO2
predicted the mixed muscle protein synthesis rate in 144 healthy
men and women aged 63–73 y (mean peak _VO2 for men: 27.5
mL  kg21  min21), but it only accounted for a small proportion
(4–5%) of the variance in these models.
This study had some limitations. The controlled meals were
consumed for only 3 d, and a longer exposure to this protein
intake or nitrogen balance status may be necessary to reveal
correlations with whole-body andmuscle protein metabolism. On
average, body weight during the research meals was lower than
habitual, so we may have underestimated protein and energy
requirements for these men. This may induce an energy deficit
large enough to obscure any effect of acutely altering protein
intake on the muscle protein metabolism variables. However, the
difference between habitual and research body weight was small
(20.5 6 1.7 kg), these measures were separated by 55 6 30 d,
and the actual energy deficit was only 282 6 510 kcal/d.
Whole-body protein kinetics reflect a composite of all body
proteins and may be insensitive to changes in protein and energy
intakes. For this reason, we measured mixed muscle protein
synthesis and muscle proteolytic enzyme activities. We only
studied relatively healthy, older men, so our findings cannot be
generalized to other populations (eg, older men and women with
severe sarcopenia, physical frailty, and/or comorbidities or
healthy younger men and women). An alternative study design
would involve quantifying protein metabolic variables during
both habitual and research meals, but this was not fiscally fea-
sible or practical for participants enrolled in a complex meta-
bolic study (4, 5). We only quantified fasting mixed muscle
protein synthesis rates. Because of the large number of partic-
ipants, it was not feasible to quantify synthesis rates for other
muscle proteins (eg, cytosolic, mitochondrial, or nuclear) un-
der fasting and postprandial conditions, but these may respond
differently to acute dietary changes. Intake of specific amino
acids may be a more important regulator of protein metabolism
than dietary protein or energy intakes. This would require in-
dividually removing and supplementing research meals with
select amino acids. Overall, when comparing muscle protein
metabolism variables between older and younger participants, it
is advisable to compare those consuming very similar habitual
protein and energy intakes rather than changing their intakes for
a short period (3 d) before conducting the protein metabolism
measures.
The strengths of the study included a relatively large sample of
well-characterized older men combined with baseline whole
body and muscle protein/amino acid kinetics quantified under
tightly regulated dietary conditions. Dietary deviations were
acute, but normally distributed; therefore, valid and meaningful
comparisons between changes in protein intake (compared with
habitual) and nitrogen balance could be made.
In summary, acute increases and decreases in protein intake
within 4% of habitual intake were not associated with changes in
resting whole-body and muscle protein metabolism in 65–90-y-
old free-living men. Previous reports of lower mixed muscle
protein synthesis rates in older men cannot be explained as an
artifact due to reductions in the protein content of the controlled
research meals consumed for several days before quantifying
whole-body and muscle protein metabolism. We confirmed that
an index of insulin sensitivity, among several potential regulators,
is a strong predictor of the whole-body proteolysis rate in older
men and may be a more important regulator of whole-body and
muscle protein metabolism than is controlling protein intake for
several days before quantifying protein/amino acid kinetic param-
eters in older men.
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